Tag results:

B cells

Salmonella typhi VI Capsule Prime-Boost Vaccination Induces Convergent and Functional Antibody Responses

[Science Immunology] Researchers investigated the human antibody repertoire, avidity maturation, epitope specificity, and function after immunization with a single dose of Vi-tetanus toxoid conjugate vaccine and after a booster with plain Vi polysaccharide.

Moracin D Induces Apoptosis in Prostate Cancer Cells via Activation of PPAR Gamma/PKC Delta and Inhibition of PKC Alpha

[Phytotherapy Research] Researchers explored the apoptotic mechanism of Moracin D in prostate cancer cells in association with peroxisome proliferator-activated receptor gamma (PPAR-γ)-related signaling involved in lipid metabolism.

The Intersection of COVID-19 and Autoimmunity

[Journal of Clinical Investigation] The authors highlight the current understanding, evolving concepts, and unanswered questions provided by this unique opportunity to determine mechanisms by which a viral infection can be exacerbated by, and even trigger, autoimmunity.

Role of the IgG4-Related Cholangitis Autoantigen Annexin A11 in Cholangiocyte Protection

[Journal of Hepatology] Scientists investigated the expression and function of annexin A11 in human cholangiocytes and a potential role of IgG1/IgG4-mediated autoreactivity against annexin A11 in the pathogenesis of IgG4-related cholangitis.

Microenvironmental IL-6 Inhibits Anti-Cancer Immune Responses Generated by Cytotoxic Chemotherapy

[Nature Communications] Scientists showed that chemotherapy-induced anti-cancer immunity was suppressed by the tumor microenvironment through production of the cytokine IL-6.

Precigen Announces Clearance of IND to Initiate Phase I/Ib Study for PRGN-3007 UltraCAR-T® in Advanced ROR1+ Hematological and Solid Tumors

[Precigen, Inc.] Precigen, Inc. announced that the US FDA has cleared the Investigational New Drug (IND) application to initiate the Phase I/Ib clinical trial of PRGN-3007 in advanced receptor tyrosine kinase-like orphan receptor 1-positive (ROR1+) hematological and solid tumors.

Popular